C
Claire Bouleti
Researcher at University of Poitiers
Publications - 10
Citations - 309
Claire Bouleti is an academic researcher from University of Poitiers. The author has contributed to research in topics: Placebo & Heart failure. The author has an hindex of 3, co-authored 10 publications receiving 83 citations.
Papers
More filters
Journal ArticleDOI
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study
Jules Mesnier,Yves Cottin,Pierre Coste,E. Ferrari,Francois Schiele,Gilles Lemesle,Christophe Thuaire,Denis Angoulvant,Guillaume Cayla,Claire Bouleti,Romain Gallet de Saint Aurin,Pascal Goube,Thibault Lhermusier,Jean-Guillaume Dillinger,Franck Paganelli,Anis Saib,Fabrice Prunier,Gérald Vanzetto,Olivier Dubreuil,Etienne Puymirat,Franck Boccara,Hélène Eltchaninoff,Marine Cachanado,Alexandra Rousseau,Elodie Drouet,Philippe Gabriel Steg,Tabassome Simon,Nicolas Danchin +27 more
TL;DR: A marked decrease in hospital admissions was observed following the lockdown, irrespective of patient characteristics and regional prevalence of COVID-19, and health authorities should be aware of these findings, in order to adapt their message if the CO VID-19 pandemic persists or recurs, or in case of future major epidemics.
Journal ArticleDOI
Hospital Admissions for Acute Myocardial Infarction Before and After Lockdown According to Regional Prevalence of COVID-19 and Patient Profile
Jules Mesnier,Yves Cottin,Pierre Coste,E. Ferrari,Francois Schiele,Gilles Lemesle,Christophe Thuaire,Denis Angoulvant,Guillaume Cayla,Claire Bouleti,Romain Gallet de Saint Aurin,Pascal Goube,Thibault Lhermusier,Jean-Guillaume Dillinger,Franck Paganelli,Anis Saib,Fabrice Prunier,Gérald Vanzetto,Olivier Dubreuil,Etienne Puymirat,Franck Boccara,Hélène Eltchaninoff,Marine Cachanado,Alexandra Rousseau,Elodie Drouet,Gabriel Steg,Tabassome Simon,Nicolas Danchin +27 more
TL;DR: A marked decrease in hospital admissions was observed following the lockdown, irrespective of patient characteristics and regional prevalence of COVID-19, in order to adapt their message in case of a second wave of the pandemic or future major epidemics.
Journal ArticleDOI
Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction
Nathan Mewton,François Roubille,Didier Bresson,Cyril Prieur,Claire Bouleti,Thomas Bochaton,Fabrice Ivanes,Olivier Dubreuil,Loïc Bière,Ahmad Hayek,François Derimay,Mariama Akodad,Benjamin Alos,Lamis Haider,Naoual El Jonhy,Rachel Daw,Charles De Bourguignon,Carole Dhelens,Gérard Finet,Eric Bonnefoy-Cudraz,Gabriel Bidaux,Florent Boutitie,Delphine Maucort-Boulch,Pierre Croisille,Gilles Rioufol,Fabrice Prunier,Denis Angoulvant +26 more
TL;DR: In this paper, colchicine, a potent anti-inflammatory agent, may reduce myocardial infarction in reperfused ST-segment-elevation.
Journal ArticleDOI
Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry.
Mateusz Sokolski,Mateusz Sokolski,Sander Trenson,Sander Trenson,Justyna M. Sokolska,Justyna M. Sokolska,Domenico D'Amario,Philippe Meyer,Nana K. Poku,Tor Biering-Sørensen,Mats Christian Højbjerg Lassen,Kristoffer Grundtvig Skaarup,Eduardo Barge-Caballero,Anne-Catherine Pouleur,Davide Stolfo,Gianfranco Sinagra,Klemens Ablasser,Viktoria Muster,Peter P. Rainer,Markus Wallner,Markus Wallner,Alessandra Chiodini,P S Heiniger,Fran Mikulicic,Judith Schwaiger,Stephan Winnik,Huseyin A. Cakmak,Margherita Gaudenzi,Massimo Mapelli,Irene Mattavelli,Matthias Paul,Irina Cabac-Pogorevici,Claire Bouleti,Marzia Lilliu,Chiara Minoia,Jeroen Dauw,Jérôme Costa,Ahmet Çelik,Nathan Mewton,Nathan Mewton,Carlos Eduardo Lucena Montenegro,Yuya Matsue,Goran Loncar,Goran Loncar,Michał Marchel,Aris Bechlioulis,Lampros K. Michalis,Marcus Dörr,Edgard Prihadi,Felix Schoenrath,Daniel Messroghli,Wilfried Mullens,Lars Lund,Giuseppe M.C. Rosano,Piotr Ponikowski,Frank Ruschitzka,Andreas J. Flammer +56 more
TL;DR: In this paper, the outcome of hospitalized coronavirus disease 2019 (COVID-19) patients with heart failure (HF) compared with patients with other cardiovascular disease and/or risk factors (arterial hypertension, diabetes, or dyslipidaemia).
Journal ArticleDOI
Hypnosis Versus Placebo During Atrial Flutter Ablation: The PAINLESS Study: A Randomized Controlled Trial
Rodrigue Garcia,Claire Bouleti,Anthony Li,Denis Frasca,Sophia El Harrouchi,Julien Marechal,Pierre Roumegou,Pierre Corbi,Luc Christiaens,François Le Gal,Bruno Degand +10 more
TL;DR: In this first randomized trial, hypnosis during AFL ablation was superior to placebo for alleviating pain and reducing morphine consumption.